Toggle Main Menu Toggle Search

Open Access padlockePrints

Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective

Lookup NU author(s): Dr Diarmuid CoughlanORCiD, Oluwatomi Arisa, Dr Katie ThomsonORCiD, Dr Ge YuORCiD, Dr Fiona Pearson, Dr Ashleigh KernohanORCiD, Sonia Garcia Gonzalez-MoralORCiD, Sheila WallaceORCiD, Stephen RiceORCiD



This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Coughlan D, Arisa O, Thomson K, Yu G, Pearson F, Kernohan A, Garcia Gonzalez-Moral S, Wallace S, Rice S

Publication type: Article

Publication status: Published

Journal: PharmacoEconomics

Year: 2024

Volume: 42

Pages: 5-9

Print publication date: 01/01/2024

Online publication date: 05/10/2023

Acceptance date: 27/08/2023

Date deposited: 10/10/2023

ISSN (print): 1170-7690

ISSN (electronic): 1179-2027

Publisher: Adis International Ltd.


DOI: 10.1007/s40273-023-01317-z

ePrints DOI: 10.57711/99p0-4a85


Altmetrics provided by Altmetric


Funder referenceFunder name
National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Programme (Grant number: NIHR132004)